Odyssean LLC Boosts Stock Holdings in Veeva Systems Inc. $VEEV

Odyssean LLC grew its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 144.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 18,634 shares of the technology company’s stock after buying an additional 10,997 shares during the period. Veeva Systems accounts for approximately 0.5% of Odyssean LLC’s holdings, making the stock its 16th biggest holding. Odyssean LLC’s holdings in Veeva Systems were worth $3,307,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in VEEV. SHP Wealth Management purchased a new stake in Veeva Systems during the fourth quarter valued at about $26,000. Activest Wealth Management increased its stake in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after acquiring an additional 127 shares during the last quarter. MV Capital Management Inc. purchased a new position in shares of Veeva Systems in the 4th quarter worth about $30,000. Reflection Asset Management acquired a new position in shares of Veeva Systems in the 4th quarter valued at about $32,000. Finally, BOK Financial Private Wealth Inc. acquired a new position in shares of Veeva Systems in the 4th quarter valued at about $33,000. 88.20% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the company’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the completion of the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This represents a 64.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Major Vault CRM customer wins strengthen Veeva’s competitive position. Biogen and Regeneron each committed to Veeva Vault CRM globally. The agreements support adoption of Veeva’s unified, AI-enabled commercial platform and provide further evidence of traction in the biopharmaceutical market. Veeva Vault CRM Selected by Biogen Veeva Vault CRM Selected by Regeneron
• Positive Sentiment: Truist said the wins reinforce Vault CRM’s market-leader status ahead of earnings. The analyst view suggests the customer additions could support future bookings, recurring revenue growth and broader cross-selling across Veeva’s life-sciences cloud products. Veeva’s Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist Says
• Positive Sentiment: Analyst sentiment remains favorable. Piper Sandler initiated coverage with an Overweight rating and a $295 price target, while Needham reiterated its Buy rating with a $270 target. Both targets imply additional upside from the referenced share price.
• Neutral Sentiment: Earnings are the immediate catalyst. Investors are looking for continued double-digit growth driven by Vault CRM, Falcon AI and R&D Cloud. The company’s latest reported quarter showed 16.3% year-over-year revenue growth and an earnings beat, raising expectations for another solid performance. What To Expect From Veeva Systems’s Q2 Earnings
• Negative Sentiment: Valuation leaves limited room for disappointment. Veeva trades at roughly 44 times earnings after a substantial rally, so any weakness in guidance, bookings or operating trends could prompt profit-taking. The stock’s decline ahead of results likely reflects investor caution while the market awaits confirmation of growth expectations.

Veeva Systems Stock Performance

Veeva Systems stock opened at $247.38 on Wednesday. The firm has a market capitalization of $40.18 billion, a PE ratio of 44.10, a price-to-earnings-growth ratio of 1.07 and a beta of 0.92. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50. The stock’s 50 day moving average price is $201.60 and its 200 day moving average price is $182.61.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The company had revenue of $882.95 million during the quarter, compared to the consensus estimate of $857.73 million. During the same quarter last year, the company earned $1.97 earnings per share. Veeva Systems’s revenue for the quarter was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, analysts forecast that Veeva Systems Inc. will post 6.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on VEEV. Citigroup increased their target price on shares of Veeva Systems from $176.00 to $190.00 and gave the stock a “neutral” rating in a research report on Thursday, June 4th. Stifel Nicolaus boosted their price objective on shares of Veeva Systems from $230.00 to $275.00 and gave the stock a “buy” rating in a research note on Monday, August 17th. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. UBS Group cut their target price on shares of Veeva Systems from $220.00 to $190.00 and set a “neutral” rating on the stock in a research note on Thursday, June 4th. Finally, Weiss Ratings upgraded shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 12th. Nineteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $258.08.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.